Company research

BIOVENTRIX, INC.

CIK 1283259Updated Sep 26, 2026

SecurityBVXX · NASDAQ · equity

Name history

BIOVENTRIX INC · through Apr 4, 2023CHF TECHNOLOGIES INC · through Nov 21, 2012

BVXX price & chart

Provider market data

Loading TradingView…

NASDAQ:BVXX on TradingView ↗

TradingView · Data may be delayed

About the company

We are a medical device company focused on developing, manufacturing and commercializing proprietary devices to restore left ventricular function in heart failure patients with reduced ejection fraction (“HFrEF”).

S-1/A · 2026-05-29 · 0001493152-26-026355

Company description from the cited filing.

In the news

No coverage from other publishers is available.

Seeking Alpha

U.S. IPO Weekly Recap: Clear Street Postpones Its IPO, As Japan-Based Payment Firm PayPay Submits Filings ↗

Seeking Alpha · 2026-02-14

Recent filings

D/A filing
D/A · 2026-09-09 · 0001283259-26-000004
D/A filing
D/A · 2026-09-01 · 0001283259-26-000003
S-1/A filing
S-1/A · 2026-05-29 · 0001493152-26-026355
S-1/A filing
S-1/A · 2026-05-15 · 0001493152-26-023752
D filing
D · 2026-04-24 · 0001283259-26-000002

Show 5 more recent filings

S-1/A filing
S-1/A · 2026-03-18 · 0001493152-26-010642
S-1 filing
S-1 · 2026-02-12 · 0001493152-26-006407
DRS/A filing
DRS/A · 2025-12-12 · 0001493152-25-027406
D/A filing
D/A · 2025-11-04 · 0001283259-25-000002
DRS/A filing
DRS/A · 2025-10-06 · 0001493152-25-016953

Offerings

Registration 333-293418

S-1/A · 2026-05-29 · 0001493152-26-026355

Terms from the governing filing for this registration; not a claim that the offering is open today.

Underwriters: The Benchmark Company, LLC